

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | axon ensheathment in central nervous system (GO:0032291) | 4.90709604 |
| 2 | central nervous system myelination (GO:0022010) | 4.90709604 |
| 3 | fatty acid elongation (GO:0030497) | 3.83237767 |
| 4 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.55090694 |
| 5 | neuron recognition (GO:0008038) | 3.48019509 |
| 6 | neuron remodeling (GO:0016322) | 3.43598447 |
| 7 | nucleobase catabolic process (GO:0046113) | 3.39015281 |
| 8 | cellular response to epinephrine stimulus (GO:0071872) | 3.34946462 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.32638430 |
| 10 | neuron cell-cell adhesion (GO:0007158) | 3.27856221 |
| 11 | T-helper 1 type immune response (GO:0042088) | 3.23979497 |
| 12 | negative regulation of protein localization to cell surface (GO:2000009) | 3.20552615 |
| 13 | response to methylmercury (GO:0051597) | 3.19740003 |
| 14 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.04419769 |
| 15 | long-chain fatty acid biosynthetic process (GO:0042759) | 3.02952715 |
| 16 | dendritic spine morphogenesis (GO:0060997) | 3.02093952 |
| 17 | positive regulation of fibroblast migration (GO:0010763) | 2.94542587 |
| 18 | positive regulation of type 2 immune response (GO:0002830) | 2.93958376 |
| 19 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.90533856 |
| 20 | axonal fasciculation (GO:0007413) | 2.90116864 |
| 21 | detection of molecule of bacterial origin (GO:0032490) | 2.89448496 |
| 22 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.89403659 |
| 23 | L-phenylalanine catabolic process (GO:0006559) | 2.89260704 |
| 24 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.89260704 |
| 25 | glutamate receptor signaling pathway (GO:0007215) | 2.88975302 |
| 26 | cellular response to growth hormone stimulus (GO:0071378) | 2.85812248 |
| 27 | negative regulation of neurotransmitter transport (GO:0051589) | 2.84497140 |
| 28 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.74791510 |
| 29 | negative regulation of interleukin-12 production (GO:0032695) | 2.72623584 |
| 30 | L-amino acid import (GO:0043092) | 2.72195818 |
| 31 | macrophage activation involved in immune response (GO:0002281) | 2.71786184 |
| 32 | response to peptidoglycan (GO:0032494) | 2.69771084 |
| 33 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.68883394 |
| 34 | positive regulation by symbiont of host defense response (GO:0052509) | 2.64626996 |
| 35 | modulation by symbiont of host defense response (GO:0052031) | 2.64626996 |
| 36 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.64626996 |
| 37 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.64626996 |
| 38 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.64626996 |
| 39 | modulation by symbiont of host immune response (GO:0052553) | 2.64626996 |
| 40 | cellular extravasation (GO:0045123) | 2.63280022 |
| 41 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.61479082 |
| 42 | myelination (GO:0042552) | 2.61418484 |
| 43 | ensheathment of neurons (GO:0007272) | 2.59531453 |
| 44 | axon ensheathment (GO:0008366) | 2.59531453 |
| 45 | neutrophil activation involved in immune response (GO:0002283) | 2.59389443 |
| 46 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.58237758 |
| 47 | leukocyte aggregation (GO:0070486) | 2.56638262 |
| 48 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.54071538 |
| 49 | response to epinephrine (GO:0071871) | 2.53299604 |
| 50 | vocalization behavior (GO:0071625) | 2.51366911 |
| 51 | regulation of collateral sprouting (GO:0048670) | 2.50305105 |
| 52 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.48279280 |
| 53 | establishment of mitochondrion localization (GO:0051654) | 2.48259243 |
| 54 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.47004306 |
| 55 | low-density lipoprotein particle clearance (GO:0034383) | 2.45906854 |
| 56 | germinal center formation (GO:0002467) | 2.44783472 |
| 57 | presynaptic membrane organization (GO:0097090) | 2.44642950 |
| 58 | cholesterol biosynthetic process (GO:0006695) | 2.44202084 |
| 59 | regulation of ARF protein signal transduction (GO:0032012) | 2.44122500 |
| 60 | mannose metabolic process (GO:0006013) | 2.43661694 |
| 61 | regulation of type 2 immune response (GO:0002828) | 2.43527395 |
| 62 | cellular response to catecholamine stimulus (GO:0071870) | 2.42558774 |
| 63 | cellular response to monoamine stimulus (GO:0071868) | 2.42558774 |
| 64 | regulation of glutamate secretion (GO:0014048) | 2.42309799 |
| 65 | cellular ketone body metabolic process (GO:0046950) | 2.42091323 |
| 66 | protein localization to synapse (GO:0035418) | 2.40712133 |
| 67 | regulation of gamma-delta T cell activation (GO:0046643) | 2.40431417 |
| 68 | positive regulation of Rap GTPase activity (GO:0032854) | 2.39440891 |
| 69 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.38731565 |
| 70 | growth hormone receptor signaling pathway (GO:0060396) | 2.37774514 |
| 71 | detection of external biotic stimulus (GO:0098581) | 2.36029572 |
| 72 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.34795790 |
| 73 | negative regulation of cell killing (GO:0031342) | 2.34175319 |
| 74 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.34175319 |
| 75 | presynaptic membrane assembly (GO:0097105) | 2.33687903 |
| 76 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.32561663 |
| 77 | positive regulation of mast cell activation (GO:0033005) | 2.32109056 |
| 78 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.31490291 |
| 79 | L-phenylalanine metabolic process (GO:0006558) | 2.31490291 |
| 80 | regulation of mast cell degranulation (GO:0043304) | 2.31460813 |
| 81 | dendrite morphogenesis (GO:0048813) | 2.30709172 |
| 82 | glucocorticoid biosynthetic process (GO:0006704) | 2.30308637 |
| 83 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.29935592 |
| 84 | detection of other organism (GO:0098543) | 2.29603686 |
| 85 | positive regulation of chemokine secretion (GO:0090197) | 2.28354076 |
| 86 | creatine metabolic process (GO:0006600) | 2.28130534 |
| 87 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.27960837 |
| 88 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.27960837 |
| 89 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.27671010 |
| 90 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.26457128 |
| 91 | nerve growth factor signaling pathway (GO:0038180) | 2.26160132 |
| 92 | very long-chain fatty acid metabolic process (GO:0000038) | 2.25090987 |
| 93 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.24642192 |
| 94 | regulation of dendritic spine development (GO:0060998) | 2.24054026 |
| 95 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.22535110 |
| 96 | sterol biosynthetic process (GO:0016126) | 2.22307718 |
| 97 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.20871839 |
| 98 | response to muramyl dipeptide (GO:0032495) | 2.20820749 |
| 99 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.20545500 |
| 100 | cellular response to antibiotic (GO:0071236) | 2.20043061 |
| 101 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.19831227 |
| 102 | regulation of mast cell activation (GO:0033003) | 2.19615266 |
| 103 | layer formation in cerebral cortex (GO:0021819) | 2.19611539 |
| 104 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.19386272 |
| 105 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.19165737 |
| 106 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.19041087 |
| 107 | plasma lipoprotein particle clearance (GO:0034381) | 2.18563478 |
| 108 | fatty-acyl-CoA metabolic process (GO:0035337) | 2.18322037 |
| 109 | cell migration involved in heart development (GO:0060973) | 2.18269525 |
| 110 | response to nerve growth factor (GO:1990089) | 2.17234562 |
| 111 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.17234562 |
| 112 | neuronal action potential propagation (GO:0019227) | 2.16980810 |
| 113 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.16918869 |
| 114 | transmission of nerve impulse (GO:0019226) | 2.16403570 |
| 115 | cardiac ventricle formation (GO:0003211) | 2.16324495 |
| 116 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.15538300 |
| 117 | regulation of lipoprotein metabolic process (GO:0050746) | 2.15479518 |
| 118 | aromatic amino acid family catabolic process (GO:0009074) | 2.14487957 |
| 119 | positive regulation of extracellular matrix organization (GO:1903055) | 2.14103814 |
| 120 | cellular response to cadmium ion (GO:0071276) | 2.13704306 |
| 121 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 2.13093140 |
| 122 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.12991661 |
| 123 | regulation of leukocyte degranulation (GO:0043300) | 2.12238535 |
| 124 | ATP synthesis coupled proton transport (GO:0015986) | 2.11672317 |
| 125 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.11672317 |
| 126 | Rap protein signal transduction (GO:0032486) | 2.11648224 |
| 127 | macrophage activation (GO:0042116) | 2.11436912 |
| 128 | positive regulation of mast cell degranulation (GO:0043306) | 2.11276112 |
| 129 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.11276112 |
| 130 | substantia nigra development (GO:0021762) | 2.10807883 |
| 131 | glucocorticoid metabolic process (GO:0008211) | 2.10556127 |
| 132 | positive regulation of oligodendrocyte differentiation (GO:0048714) | 2.10270229 |
| 133 | regulation of cholesterol storage (GO:0010885) | 2.09995929 |
| 134 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.09990469 |
| 135 | granulocyte activation (GO:0036230) | 2.09887709 |
| 136 | synaptic vesicle exocytosis (GO:0016079) | 2.09765757 |
| 137 | regulation of fibrinolysis (GO:0051917) | 2.09493668 |
| 138 | myelin maintenance (GO:0043217) | 2.09365661 |
| 139 | mating behavior (GO:0007617) | 2.08508993 |
| 140 | regulation of Rap GTPase activity (GO:0032317) | 2.07915163 |
| 141 | detection of bacterium (GO:0016045) | 2.07628376 |
| 142 | opsonization (GO:0008228) | 2.07505428 |
| 143 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.07435744 |
| 144 | ketone body metabolic process (GO:1902224) | 2.07405832 |
| 145 | B cell receptor signaling pathway (GO:0050853) | 2.07334350 |
| 146 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.06823024 |
| 147 | cellular response to toxic substance (GO:0097237) | 2.06518972 |
| 148 | sialylation (GO:0097503) | 2.06500681 |
| 149 | C21-steroid hormone biosynthetic process (GO:0006700) | 2.06313858 |
| 150 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.06300555 |
| 151 | regulation of filopodium assembly (GO:0051489) | 2.06046985 |
| 152 | positive regulation of interleukin-17 production (GO:0032740) | 2.05978796 |
| 153 | negative regulation of microtubule polymerization (GO:0031115) | 2.05539158 |
| 154 | neutrophil activation (GO:0042119) | 2.05388443 |
| 155 | exploration behavior (GO:0035640) | 2.05333794 |
| 156 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.05321210 |
| 157 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.05078329 |
| 158 | establishment of endothelial barrier (GO:0061028) | 2.05040149 |
| 159 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 2.04982110 |
| 160 | myeloid dendritic cell differentiation (GO:0043011) | 2.04684593 |
| 161 | glyoxylate metabolic process (GO:0046487) | 2.04180042 |
| 162 | cellular response to follicle-stimulating hormone stimulus (GO:0071372) | 2.03476054 |
| 163 | positive regulation of dendritic spine development (GO:0060999) | 2.03354652 |
| 164 | positive regulation of synapse assembly (GO:0051965) | 2.03079983 |
| 165 | negative regulation of axon extension (GO:0030517) | 2.02902487 |
| 166 | regulation of regulated secretory pathway (GO:1903305) | 2.02382693 |
| 167 | membrane tubulation (GO:0097320) | 2.02212354 |
| 168 | neutrophil chemotaxis (GO:0030593) | 2.01939206 |
| 169 | negative regulation of axonogenesis (GO:0050771) | 2.00979012 |
| 170 | coenzyme catabolic process (GO:0009109) | 2.00902300 |
| 171 | cAMP biosynthetic process (GO:0006171) | 2.00825699 |
| 172 | cofactor catabolic process (GO:0051187) | 2.00781900 |
| 173 | detection of biotic stimulus (GO:0009595) | 2.00552588 |
| 174 | acetyl-CoA metabolic process (GO:0006084) | 2.00078673 |
| 175 | negative regulation of production of molecular mediator of immune response (GO:0002701) | 1.99776195 |
| 176 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 1.99601948 |
| 177 | heme transport (GO:0015886) | 1.99475981 |
| 178 | regulation of gamma-delta T cell differentiation (GO:0045586) | 1.99245843 |
| 179 | iron coordination entity transport (GO:1901678) | 1.99151425 |
| 180 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 1.98470232 |
| 181 | negative regulation of granulocyte differentiation (GO:0030853) | 1.97543422 |
| 182 | glycosphingolipid biosynthetic process (GO:0006688) | 1.97468766 |
| 183 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 1.97310050 |
| 184 | toxin metabolic process (GO:0009404) | 1.97194562 |
| 185 | positive regulation of filopodium assembly (GO:0051491) | 1.97140198 |
| 186 | thioester biosynthetic process (GO:0035384) | 1.96596542 |
| 187 | acyl-CoA biosynthetic process (GO:0071616) | 1.96596542 |
| 188 | neuron-neuron synaptic transmission (GO:0007270) | 1.96547076 |
| 189 | neutrophil migration (GO:1990266) | 1.96452009 |
| 190 | activation of protein kinase A activity (GO:0034199) | 1.96422161 |
| 191 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 1.96327229 |
| 192 | positive regulation of heat generation (GO:0031652) | 1.94971419 |
| 193 | behavioral response to cocaine (GO:0048148) | 1.94352392 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.63696312 |
| 2 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.95672443 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.86725823 |
| 4 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.67629176 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.53254454 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.50782312 |
| 7 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.48550512 |
| 8 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.25157407 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.19961536 |
| 10 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.19512302 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.18389805 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.16240571 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.16240571 |
| 14 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.13202386 |
| 15 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.11637080 |
| 16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.05739213 |
| 17 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.04373052 |
| 18 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.02151969 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.00642266 |
| 20 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.00531131 |
| 21 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.93645796 |
| 22 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.91798890 |
| 23 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.89206825 |
| 24 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.87945212 |
| 25 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.85783690 |
| 26 | * RUNX_20019798_ChIP-Seq_JUKART_Human | 1.85251720 |
| 27 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.84878727 |
| 28 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.80798833 |
| 29 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.79507366 |
| 30 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.68675032 |
| 31 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.67877439 |
| 32 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.65383647 |
| 33 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.61146946 |
| 34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.57605445 |
| 35 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.57604958 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.57162434 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.55189831 |
| 38 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.52200556 |
| 39 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.51712383 |
| 40 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.50602845 |
| 41 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.49238795 |
| 42 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.48008976 |
| 43 | KDM2B_26808549_Chip-Seq_K562_Human | 1.47747973 |
| 44 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.47114864 |
| 45 | P300_19829295_ChIP-Seq_ESCs_Human | 1.46991824 |
| 46 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.46491791 |
| 47 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.46431285 |
| 48 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.46381945 |
| 49 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46169660 |
| 50 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.45560362 |
| 51 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.45011378 |
| 52 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.44986837 |
| 53 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.44595235 |
| 54 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.44425324 |
| 55 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.43940406 |
| 56 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.43907507 |
| 57 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.43741543 |
| 58 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.42194089 |
| 59 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.41510848 |
| 60 | VDR_22108803_ChIP-Seq_LS180_Human | 1.39396579 |
| 61 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.36566117 |
| 62 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.36556115 |
| 63 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.33280171 |
| 64 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.30208622 |
| 65 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.29673545 |
| 66 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.29508573 |
| 67 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.28706025 |
| 68 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.27561139 |
| 69 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.26709809 |
| 70 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.26201905 |
| 71 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.25174208 |
| 72 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.23872163 |
| 73 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.23799367 |
| 74 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.23241789 |
| 75 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.22950781 |
| 76 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.21679394 |
| 77 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.21055762 |
| 78 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20787767 |
| 79 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.18882349 |
| 80 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.17235657 |
| 81 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.16339084 |
| 82 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.15972129 |
| 83 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.13838309 |
| 84 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.13420592 |
| 85 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.12945880 |
| 86 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.12355445 |
| 87 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.12355445 |
| 88 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.11892266 |
| 89 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.11191103 |
| 90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.11141784 |
| 91 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10862597 |
| 92 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.10111702 |
| 93 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.10000169 |
| 94 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.09697517 |
| 95 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.09548414 |
| 96 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.08692807 |
| 97 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.08384090 |
| 98 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.08285663 |
| 99 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06950546 |
| 100 | TP53_16413492_ChIP-PET_HCT116_Human | 1.05863566 |
| 101 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.05746367 |
| 102 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.05440382 |
| 103 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.05372041 |
| 104 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.05184697 |
| 105 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.05110855 |
| 106 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.03772406 |
| 107 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03645322 |
| 108 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.02971240 |
| 109 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02945521 |
| 110 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.02731576 |
| 111 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.02182835 |
| 112 | * GATA1_19941826_ChIP-Seq_K562_Human | 1.02044606 |
| 113 | AR_25329375_ChIP-Seq_VCAP_Human | 1.01426158 |
| 114 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.01182393 |
| 115 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01038480 |
| 116 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.00830328 |
| 117 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.99796134 |
| 118 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.98649659 |
| 119 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97578577 |
| 120 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.97524300 |
| 121 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.97178854 |
| 122 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96860206 |
| 123 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.96754984 |
| 124 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96387869 |
| 125 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.96234937 |
| 126 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.96042681 |
| 127 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.95887060 |
| 128 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.95504226 |
| 129 | KDM2B_26808549_Chip-Seq_REH_Human | 0.94568183 |
| 130 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.92881032 |
| 131 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.92105575 |
| 132 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.91138989 |
| 133 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.89958420 |
| 134 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89916989 |
| 135 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.89460607 |
| 136 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.88684592 |
| 137 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.88415863 |
| 138 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.88054597 |
| 139 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.87901525 |
| 140 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.87636087 |
| 141 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.87399943 |
| 142 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.87199735 |
| 143 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.87125385 |
| 144 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.86293234 |
| 145 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.86293234 |
| 146 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.85433346 |
| 147 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.85222243 |
| 148 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84948315 |
| 149 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 0.84690738 |
| 150 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.84184498 |
| 151 | * SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.83545379 |
| 152 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.83193334 |
| 153 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.82737377 |
| 154 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.82537366 |
| 155 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.81692849 |
| 156 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.80727813 |
| 157 | FUS_26573619_Chip-Seq_HEK293_Human | 0.80503460 |
| 158 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.80389463 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003880_abnormal_central_pattern | 4.58147016 |
| 2 | MP0004859_abnormal_synaptic_plasticity | 3.23998140 |
| 3 | MP0000920_abnormal_myelination | 2.71905519 |
| 4 | MP0003436_decreased_susceptibility_to | 2.54928961 |
| 5 | MP0003329_amyloid_beta_deposits | 2.50121438 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 2.49026286 |
| 7 | MP0004270_analgesia | 2.48313347 |
| 8 | MP0002063_abnormal_learning/memory/cond | 2.17550126 |
| 9 | MP0000465_gastrointestinal_hemorrhage | 2.14261300 |
| 10 | MP0004510_myositis | 2.14239565 |
| 11 | MP0009745_abnormal_behavioral_response | 2.10899984 |
| 12 | MP0002064_seizures | 2.07295301 |
| 13 | MP0005423_abnormal_somatic_nervous | 2.05587795 |
| 14 | MP0005360_urolithiasis | 2.03229102 |
| 15 | MP0000604_amyloidosis | 2.02874247 |
| 16 | MP0005671_abnormal_response_to | 1.98910665 |
| 17 | MP0000778_abnormal_nervous_system | 1.98320013 |
| 18 | MP0001486_abnormal_startle_reflex | 1.96376460 |
| 19 | MP0008004_abnormal_stomach_pH | 1.93371132 |
| 20 | MP0003690_abnormal_glial_cell | 1.92044688 |
| 21 | MP0002272_abnormal_nervous_system | 1.90860330 |
| 22 | MP0000343_altered_response_to | 1.90702438 |
| 23 | MP0001440_abnormal_grooming_behavior | 1.90293224 |
| 24 | MP0002572_abnormal_emotion/affect_behav | 1.88437058 |
| 25 | MP0001800_abnormal_humoral_immune | 1.86499077 |
| 26 | MP0001501_abnormal_sleep_pattern | 1.85907872 |
| 27 | MP0002139_abnormal_hepatobiliary_system | 1.84941670 |
| 28 | MP0003828_pulmonary_edema | 1.84541384 |
| 29 | MP0009785_altered_susceptibility_to | 1.84189083 |
| 30 | MP0005025_abnormal_response_to | 1.80872774 |
| 31 | MP0009840_abnormal_foam_cell | 1.79171220 |
| 32 | MP0002998_abnormal_bone_remodeling | 1.77622869 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.72546140 |
| 34 | MP0002837_dystrophic_cardiac_calcinosis | 1.70036433 |
| 35 | MP0001968_abnormal_touch/_nociception | 1.68183955 |
| 36 | MP0002452_abnormal_antigen_presenting | 1.66296713 |
| 37 | MP0002723_abnormal_immune_serum | 1.65546903 |
| 38 | MP0004742_abnormal_vestibular_system | 1.65512999 |
| 39 | MP0002736_abnormal_nociception_after | 1.64722045 |
| 40 | MP0001905_abnormal_dopamine_level | 1.63399501 |
| 41 | MP0003303_peritoneal_inflammation | 1.63111344 |
| 42 | MP0003195_calcinosis | 1.61630078 |
| 43 | MP0002420_abnormal_adaptive_immunity | 1.57862210 |
| 44 | MP0006276_abnormal_autonomic_nervous | 1.56563864 |
| 45 | MP0001533_abnormal_skeleton_physiology | 1.54233673 |
| 46 | MP0001819_abnormal_immune_cell | 1.53814637 |
| 47 | MP0008875_abnormal_xenobiotic_pharmacok | 1.53442843 |
| 48 | MP0001529_abnormal_vocalization | 1.52645309 |
| 49 | MP0002735_abnormal_chemical_nociception | 1.46762823 |
| 50 | MP0003172_abnormal_lysosome_physiology | 1.45783558 |
| 51 | MP0000751_myopathy | 1.45145956 |
| 52 | MP0009379_abnormal_foot_pigmentation | 1.43502942 |
| 53 | MP0004947_skin_inflammation | 1.43282432 |
| 54 | MP0005058_abnormal_lysosome_morphology | 1.43107730 |
| 55 | MP0001873_stomach_inflammation | 1.40852248 |
| 56 | MP0001879_abnormal_lymphatic_vessel | 1.40580184 |
| 57 | MP0002405_respiratory_system_inflammati | 1.39820062 |
| 58 | MP0003724_increased_susceptibility_to | 1.39742849 |
| 59 | MP0005409_darkened_coat_color | 1.37282979 |
| 60 | MP0005083_abnormal_biliary_tract | 1.34491800 |
| 61 | MP0010368_abnormal_lymphatic_system | 1.33185446 |
| 62 | MP0009046_muscle_twitch | 1.32895211 |
| 63 | MP0002734_abnormal_mechanical_nocicepti | 1.31880545 |
| 64 | MP0005085_abnormal_gallbladder_physiolo | 1.31745137 |
| 65 | MP0002067_abnormal_sensory_capabilities | 1.31227097 |
| 66 | MP0003191_abnormal_cellular_cholesterol | 1.21689762 |
| 67 | MP0003633_abnormal_nervous_system | 1.21523281 |
| 68 | MP0000685_abnormal_immune_system | 1.21173797 |
| 69 | MP0003634_abnormal_glial_cell | 1.20642964 |
| 70 | MP0009278_abnormal_bone_marrow | 1.20084459 |
| 71 | MP0003091_abnormal_cell_migration | 1.18613406 |
| 72 | MP0003879_abnormal_hair_cell | 1.16902008 |
| 73 | MP0002184_abnormal_innervation | 1.15883709 |
| 74 | MP0005535_abnormal_body_temperature | 1.14724386 |
| 75 | MP0001845_abnormal_inflammatory_respons | 1.14175100 |
| 76 | MP0003075_altered_response_to | 1.14094722 |
| 77 | MP0003631_nervous_system_phenotype | 1.13642165 |
| 78 | MP0002733_abnormal_thermal_nociception | 1.13147975 |
| 79 | MP0005666_abnormal_adipose_tissue | 1.12091152 |
| 80 | MP0005167_abnormal_blood-brain_barrier | 1.10975622 |
| 81 | MP0006082_CNS_inflammation | 1.08280788 |
| 82 | MP0001970_abnormal_pain_threshold | 1.08018693 |
| 83 | MP0004885_abnormal_endolymph | 1.07563965 |
| 84 | MP0002933_joint_inflammation | 1.07034442 |
| 85 | MP0003763_abnormal_thymus_physiology | 1.06873950 |
| 86 | MP0005386_behavior/neurological_phenoty | 1.06510165 |
| 87 | MP0004924_abnormal_behavior | 1.06510165 |
| 88 | MP0005365_abnormal_bile_salt | 1.06407127 |
| 89 | MP0004381_abnormal_hair_follicle | 1.05768679 |
| 90 | MP0005164_abnormal_response_to | 1.04229996 |
| 91 | MP0004883_abnormal_blood_vessel | 1.01975376 |
| 92 | MP0000249_abnormal_blood_vessel | 1.01860439 |
| 93 | MP0004142_abnormal_muscle_tone | 1.01224125 |
| 94 | MP0005334_abnormal_fat_pad | 1.01183673 |
| 95 | MP0002066_abnormal_motor_capabilities/c | 1.01049388 |
| 96 | MP0008874_decreased_physiological_sensi | 1.00234429 |
| 97 | MP0000716_abnormal_immune_system | 1.00182948 |
| 98 | MP0004484_altered_response_of | 0.99656718 |
| 99 | MP0009115_abnormal_fat_cell | 0.99489878 |
| 100 | MP0010155_abnormal_intestine_physiology | 0.98045146 |
| 101 | MP0002909_abnormal_adrenal_gland | 0.98029504 |
| 102 | MP0005464_abnormal_platelet_physiology | 0.97489860 |
| 103 | MP0000569_abnormal_digit_pigmentation | 0.97476441 |
| 104 | MP0004036_abnormal_muscle_relaxation | 0.96921489 |
| 105 | MP0001790_abnormal_immune_system | 0.96659339 |
| 106 | MP0005387_immune_system_phenotype | 0.96659339 |
| 107 | MP0001851_eye_inflammation | 0.95951549 |
| 108 | MP0003632_abnormal_nervous_system | 0.95382736 |
| 109 | MP0005375_adipose_tissue_phenotype | 0.94557546 |
| 110 | MP0008569_lethality_at_weaning | 0.94529350 |
| 111 | MP0005310_abnormal_salivary_gland | 0.94221552 |
| 112 | MP0004130_abnormal_muscle_cell | 0.92749707 |
| 113 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.92510085 |
| 114 | MP0010329_abnormal_lipoprotein_level | 0.91610360 |
| 115 | MP0002295_abnormal_pulmonary_circulatio | 0.90392605 |
| 116 | MP0005451_abnormal_body_composition | 0.88760395 |
| 117 | MP0002557_abnormal_social/conspecific_i | 0.88181503 |
| 118 | MP0002882_abnormal_neuron_morphology | 0.86702125 |
| 119 | MP0005595_abnormal_vascular_smooth | 0.84422009 |
| 120 | MP0001849_ear_inflammation | 0.83576260 |
| 121 | MP0005332_abnormal_amino_acid | 0.82126450 |
| 122 | MP0000955_abnormal_spinal_cord | 0.81943622 |
| 123 | MP0002118_abnormal_lipid_homeostasis | 0.81762646 |
| 124 | MP0000767_abnormal_smooth_muscle | 0.81615488 |
| 125 | MP0002229_neurodegeneration | 0.81114299 |
| 126 | MP0003279_aneurysm | 0.78787124 |
| 127 | MP0008469_abnormal_protein_level | 0.78659139 |
| 128 | MP0002398_abnormal_bone_marrow | 0.78330723 |
| 129 | MP0005645_abnormal_hypothalamus_physiol | 0.75367918 |
| 130 | MP0004085_abnormal_heartbeat | 0.75299128 |
| 131 | MP0001663_abnormal_digestive_system | 0.75201082 |
| 132 | MP0004858_abnormal_nervous_system | 0.74887413 |
| 133 | MP0001958_emphysema | 0.74155198 |
| 134 | MP0004811_abnormal_neuron_physiology | 0.72970937 |
| 135 | MP0002332_abnormal_exercise_endurance | 0.72725583 |
| 136 | MP0004782_abnormal_surfactant_physiolog | 0.72395253 |
| 137 | MP0005000_abnormal_immune_tolerance | 0.72195658 |
| 138 | MP0005388_respiratory_system_phenotype | 0.72148223 |
| 139 | MP0002133_abnormal_respiratory_system | 0.72148223 |
| 140 | MP0005166_decreased_susceptibility_to | 0.71750458 |
| 141 | MP0001502_abnormal_circadian_rhythm | 0.71413800 |
| 142 | MP0002138_abnormal_hepatobiliary_system | 0.70719374 |
| 143 | MP0002254_reproductive_system_inflammat | 0.70009748 |
| 144 | MP0002419_abnormal_innate_immunity | 0.68800649 |
| 145 | MP0002148_abnormal_hypersensitivity_rea | 0.66703426 |
| 146 | MP0000230_abnormal_systemic_arterial | 0.63835643 |
| 147 | MP0005410_abnormal_fertilization | 0.63317039 |
| 148 | MP0004145_abnormal_muscle_electrophysio | 0.62519561 |
| 149 | MP0009764_decreased_sensitivity_to | 0.61514244 |
| 150 | MP0001963_abnormal_hearing_physiology | 0.61357283 |
| 151 | MP0005551_abnormal_eye_electrophysiolog | 0.60592185 |
| 152 | MP0001835_abnormal_antigen_presentation | 0.60345043 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Neurofibrillary tangles (HP:0002185) | 5.73668156 |
| 2 | Cerebral inclusion bodies (HP:0100314) | 5.26653206 |
| 3 | Autoimmune thrombocytopenia (HP:0001973) | 5.03252996 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.29726546 |
| 5 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.09251024 |
| 6 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.09251024 |
| 7 | Supranuclear gaze palsy (HP:0000605) | 3.76608824 |
| 8 | Abnormality of the corticospinal tract (HP:0002492) | 3.65110967 |
| 9 | Insidious onset (HP:0003587) | 3.57842430 |
| 10 | Termporal pattern (HP:0011008) | 3.57842430 |
| 11 | Cerebral hemorrhage (HP:0001342) | 3.56323569 |
| 12 | Abnormality of macrophages (HP:0004311) | 3.55079978 |
| 13 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.54177484 |
| 14 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.54177484 |
| 15 | Abnormality of glycolipid metabolism (HP:0010969) | 3.54177484 |
| 16 | Increased IgM level (HP:0003496) | 3.32681038 |
| 17 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.31962878 |
| 18 | Focal motor seizures (HP:0011153) | 3.22408989 |
| 19 | Deep venous thrombosis (HP:0002625) | 3.18914092 |
| 20 | Hyperventilation (HP:0002883) | 3.15140833 |
| 21 | Parakeratosis (HP:0001036) | 3.07748395 |
| 22 | Recurrent abscess formation (HP:0002722) | 2.97066647 |
| 23 | Autoimmune hemolytic anemia (HP:0001890) | 2.97041077 |
| 24 | Hyperlipoproteinemia (HP:0010980) | 2.86473847 |
| 25 | Myokymia (HP:0002411) | 2.83414233 |
| 26 | Retrobulbar optic neuritis (HP:0100654) | 2.79202450 |
| 27 | Optic neuritis (HP:0100653) | 2.79202450 |
| 28 | Abnormality of T cell number (HP:0011839) | 2.78972196 |
| 29 | Axonal loss (HP:0003447) | 2.75283842 |
| 30 | Orchitis (HP:0100796) | 2.74407049 |
| 31 | Prolonged partial thromboplastin time (HP:0003645) | 2.73056095 |
| 32 | Cellulitis (HP:0100658) | 2.72805768 |
| 33 | Dysmetria (HP:0001310) | 2.71785468 |
| 34 | Action tremor (HP:0002345) | 2.68109334 |
| 35 | Myositis (HP:0100614) | 2.67711686 |
| 36 | Focal seizures (HP:0007359) | 2.66823798 |
| 37 | Abnormality of glycolysis (HP:0004366) | 2.66375551 |
| 38 | Increased serum pyruvate (HP:0003542) | 2.66375551 |
| 39 | Neonatal hypoglycemia (HP:0001998) | 2.65558579 |
| 40 | Mediastinal lymphadenopathy (HP:0100721) | 2.59684554 |
| 41 | Onion bulb formation (HP:0003383) | 2.58120905 |
| 42 | Vasculitis (HP:0002633) | 2.55909258 |
| 43 | Abnormality of the fingertips (HP:0001211) | 2.53628710 |
| 44 | Obstructive sleep apnea (HP:0002870) | 2.51191755 |
| 45 | Papilledema (HP:0001085) | 2.51005226 |
| 46 | Amyloidosis (HP:0011034) | 2.50805614 |
| 47 | Dysostosis multiplex (HP:0000943) | 2.46020718 |
| 48 | Eosinophilia (HP:0001880) | 2.37895834 |
| 49 | Hemiparesis (HP:0001269) | 2.36923328 |
| 50 | Acute necrotizing encephalopathy (HP:0006965) | 2.36239702 |
| 51 | Spastic gait (HP:0002064) | 2.33712313 |
| 52 | Amblyopia (HP:0000646) | 2.32236626 |
| 53 | Retinal dysplasia (HP:0007973) | 2.31433709 |
| 54 | Peripheral hypomyelination (HP:0007182) | 2.31367260 |
| 55 | Meningitis (HP:0001287) | 2.31255108 |
| 56 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.31108408 |
| 57 | Diminished motivation (HP:0000745) | 2.29212848 |
| 58 | Hypophosphatemic rickets (HP:0004912) | 2.28503091 |
| 59 | Loss of speech (HP:0002371) | 2.26079178 |
| 60 | Ankle clonus (HP:0011448) | 2.25324167 |
| 61 | Ulnar claw (HP:0001178) | 2.25218845 |
| 62 | Xanthomatosis (HP:0000991) | 2.24764609 |
| 63 | Disinhibition (HP:0000734) | 2.22258021 |
| 64 | Acute encephalopathy (HP:0006846) | 2.21231517 |
| 65 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.20702051 |
| 66 | Abnormality of the columella (HP:0009929) | 2.20269251 |
| 67 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.18788661 |
| 68 | Enlarged epiphyses (HP:0010580) | 2.18373159 |
| 69 | Clumsiness (HP:0002312) | 2.18219614 |
| 70 | Scanning speech (HP:0002168) | 2.18096316 |
| 71 | Hypochromic anemia (HP:0001931) | 2.17530626 |
| 72 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.17415343 |
| 73 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.16815483 |
| 74 | Drooling (HP:0002307) | 2.16017337 |
| 75 | Excessive salivation (HP:0003781) | 2.16017337 |
| 76 | Urticaria (HP:0001025) | 2.13741517 |
| 77 | Hemiplegia (HP:0002301) | 2.13590649 |
| 78 | Increased circulating renin level (HP:0000848) | 2.13068316 |
| 79 | Intention tremor (HP:0002080) | 2.12903106 |
| 80 | Broad-based gait (HP:0002136) | 2.11810720 |
| 81 | Increased cerebral lipofuscin (HP:0011813) | 2.11025268 |
| 82 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.11005174 |
| 83 | Urinary urgency (HP:0000012) | 2.10827964 |
| 84 | Dialeptic seizures (HP:0011146) | 2.09689820 |
| 85 | Progressive cerebellar ataxia (HP:0002073) | 2.09434436 |
| 86 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.08501590 |
| 87 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.08501590 |
| 88 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.08501590 |
| 89 | Osteomyelitis (HP:0002754) | 2.08145890 |
| 90 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.07732832 |
| 91 | Keratoconjunctivitis sicca (HP:0001097) | 2.07468299 |
| 92 | Progressive macrocephaly (HP:0004481) | 2.07449750 |
| 93 | Leukodystrophy (HP:0002415) | 2.06336562 |
| 94 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.06092185 |
| 95 | Absence seizures (HP:0002121) | 2.05872725 |
| 96 | Conjunctival telangiectasia (HP:0000524) | 2.05836986 |
| 97 | Generalized tonic-clonic seizures (HP:0002069) | 2.05700028 |
| 98 | Leukocytosis (HP:0001974) | 2.03967249 |
| 99 | Hematochezia (HP:0002573) | 2.03762713 |
| 100 | Atonic seizures (HP:0010819) | 2.02940130 |
| 101 | Abnormality of the right ventricle (HP:0001707) | 2.02845026 |
| 102 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.02543104 |
| 103 | Mucopolysacchariduria (HP:0008155) | 2.02543104 |
| 104 | Joint hemorrhage (HP:0005261) | 2.02519242 |
| 105 | Cerebral edema (HP:0002181) | 2.02411834 |
| 106 | Psychosis (HP:0000709) | 1.99939258 |
| 107 | Chronic obstructive pulmonary disease (HP:0006510) | 1.99485548 |
| 108 | Obstructive lung disease (HP:0006536) | 1.99485548 |
| 109 | Truncal ataxia (HP:0002078) | 1.99389635 |
| 110 | Buphthalmos (HP:0000557) | 1.99230391 |
| 111 | Gastrointestinal stroma tumor (HP:0100723) | 1.98968846 |
| 112 | Granulocytopenia (HP:0001913) | 1.98674448 |
| 113 | Growth hormone excess (HP:0000845) | 1.97634645 |
| 114 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.97528045 |
| 115 | Complement deficiency (HP:0004431) | 1.97192248 |
| 116 | Epileptic encephalopathy (HP:0200134) | 1.96985253 |
| 117 | Interstitial pulmonary disease (HP:0006530) | 1.96593025 |
| 118 | Polycythemia (HP:0001901) | 1.96158921 |
| 119 | Verrucae (HP:0200043) | 1.96108072 |
| 120 | Papilloma (HP:0012740) | 1.96108072 |
| 121 | Hypercortisolism (HP:0001578) | 1.93914886 |
| 122 | Thickened helices (HP:0000391) | 1.92983491 |
| 123 | Hemoptysis (HP:0002105) | 1.92457762 |
| 124 | Diplopia (HP:0000651) | 1.92053517 |
| 125 | Abnormality of binocular vision (HP:0011514) | 1.92053517 |
| 126 | Pulmonary embolism (HP:0002204) | 1.90310741 |
| 127 | Slow saccadic eye movements (HP:0000514) | 1.90245274 |
| 128 | Rapidly progressive (HP:0003678) | 1.89872274 |
| 129 | Dysdiadochokinesis (HP:0002075) | 1.89810908 |
| 130 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.89300514 |
| 131 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.88993576 |
| 132 | Mutism (HP:0002300) | 1.88849728 |
| 133 | Spontaneous hematomas (HP:0007420) | 1.88750391 |
| 134 | Prolonged bleeding time (HP:0003010) | 1.88690605 |
| 135 | Progressive inability to walk (HP:0002505) | 1.88652180 |
| 136 | Ventricular fibrillation (HP:0001663) | 1.87903398 |
| 137 | Absent frontal sinuses (HP:0002688) | 1.87581518 |
| 138 | Gingivitis (HP:0000230) | 1.87363486 |
| 139 | Keratoconjunctivitis (HP:0001096) | 1.87256779 |
| 140 | Anxiety (HP:0000739) | 1.86584264 |
| 141 | Peripheral demyelination (HP:0011096) | 1.86383848 |
| 142 | Visual hallucinations (HP:0002367) | 1.84747897 |
| 143 | Abnormal eating behavior (HP:0100738) | 1.84634072 |
| 144 | Postural tremor (HP:0002174) | 1.84463025 |
| 145 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 1.84001209 |
| 146 | Recurrent fungal infections (HP:0002841) | 1.82740283 |
| 147 | Sensory axonal neuropathy (HP:0003390) | 1.82124314 |
| 148 | Abnormality of salivation (HP:0100755) | 1.80577098 |
| 149 | Lower limb muscle weakness (HP:0007340) | 1.80447065 |
| 150 | Hypergammaglobulinemia (HP:0010702) | 1.79757582 |
| 151 | Neuronal loss in central nervous system (HP:0002529) | 1.79364960 |
| 152 | Abnormality of eosinophils (HP:0001879) | 1.78772889 |
| 153 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.77327150 |
| 154 | Stomatitis (HP:0010280) | 1.75526580 |
| 155 | Abnormality of the frontal sinuses (HP:0002687) | 1.75316340 |
| 156 | Renal Fanconi syndrome (HP:0001994) | 1.75166670 |
| 157 | Cerebral aneurysm (HP:0004944) | 1.74910997 |
| 158 | Restrictive lung disease (HP:0002091) | 1.74890396 |
| 159 | Memory impairment (HP:0002354) | 1.74556796 |
| 160 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.74041256 |
| 161 | Systemic lupus erythematosus (HP:0002725) | 1.73492429 |
| 162 | Apathy (HP:0000741) | 1.72269554 |
| 163 | Poor eye contact (HP:0000817) | 1.70732860 |
| 164 | Agammaglobulinemia (HP:0004432) | 1.70467588 |
| 165 | Intrahepatic cholestasis (HP:0001406) | 1.68888541 |
| 166 | Hypobetalipoproteinemia (HP:0003563) | 1.68873521 |
| 167 | Recurrent bacterial skin infections (HP:0005406) | 1.68595561 |
| 168 | Polyphagia (HP:0002591) | 1.67145032 |
| 169 | Global brain atrophy (HP:0002283) | 1.67095908 |
| 170 | Exotropia (HP:0000577) | 1.66960961 |
| 171 | Spontaneous abortion (HP:0005268) | 1.65260706 |
| 172 | Stridor (HP:0010307) | 1.65203862 |
| 173 | Hypoplasia of the iris (HP:0007676) | 1.64589439 |
| 174 | Blue irides (HP:0000635) | 1.62550587 |
| 175 | Mitochondrial inheritance (HP:0001427) | 1.62403384 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 3.31683573 |
| 2 | MARK1 | 3.14352284 |
| 3 | EPHB1 | 2.83896015 |
| 4 | STK39 | 2.71821180 |
| 5 | EPHA4 | 2.46415066 |
| 6 | FGR | 2.32200267 |
| 7 | TLK1 | 2.24784553 |
| 8 | PIK3CA | 2.20238535 |
| 9 | SIK2 | 2.16366475 |
| 10 | PNCK | 2.10406503 |
| 11 | TAOK1 | 2.08562565 |
| 12 | PKN1 | 2.05081030 |
| 13 | MAP3K4 | 1.95534986 |
| 14 | OXSR1 | 1.91209377 |
| 15 | PRPF4B | 1.74659068 |
| 16 | NTRK3 | 1.70585930 |
| 17 | GRK7 | 1.65488828 |
| 18 | TIE1 | 1.65019345 |
| 19 | FES | 1.63224304 |
| 20 | PTK2B | 1.62795817 |
| 21 | MAP2K3 | 1.61582707 |
| 22 | ZAP70 | 1.56837367 |
| 23 | DAPK2 | 1.54100652 |
| 24 | MAP2K4 | 1.52295096 |
| 25 | MAPK13 | 1.52223884 |
| 26 | MAP2K7 | 1.52190862 |
| 27 | KDR | 1.49613773 |
| 28 | IRAK3 | 1.48247504 |
| 29 | MARK3 | 1.46379744 |
| 30 | NTRK2 | 1.45914700 |
| 31 | TRIB3 | 1.44030688 |
| 32 | BCR | 1.34179225 |
| 33 | CAMK1G | 1.32808152 |
| 34 | FGFR2 | 1.32474221 |
| 35 | UHMK1 | 1.30504384 |
| 36 | GRK5 | 1.26609150 |
| 37 | DYRK2 | 1.26296581 |
| 38 | CASK | 1.25572810 |
| 39 | WNK4 | 1.23674435 |
| 40 | CAMK2B | 1.22569628 |
| 41 | GRK6 | 1.20918224 |
| 42 | MAP3K9 | 1.18278195 |
| 43 | PAK6 | 1.17772857 |
| 44 | BMPR2 | 1.17549007 |
| 45 | CAMKK1 | 1.14589549 |
| 46 | CAMKK2 | 1.13160452 |
| 47 | MINK1 | 1.11255101 |
| 48 | BLK | 1.10528626 |
| 49 | CAMK2A | 1.07286298 |
| 50 | MAP3K3 | 1.07250226 |
| 51 | * MAPK12 | 1.06406241 |
| 52 | SIK1 | 1.06117153 |
| 53 | PDGFRB | 1.04870297 |
| 54 | MOS | 1.04810055 |
| 55 | JAK1 | 1.02016090 |
| 56 | TYK2 | 1.01082866 |
| 57 | MAP3K12 | 1.00282877 |
| 58 | CDK5 | 1.00003906 |
| 59 | TXK | 0.99929095 |
| 60 | PLK2 | 0.99557631 |
| 61 | JAK2 | 0.98780163 |
| 62 | PINK1 | 0.97125319 |
| 63 | CDC42BPA | 0.95461422 |
| 64 | SYK | 0.94930459 |
| 65 | CAMK1D | 0.94918699 |
| 66 | PRKCQ | 0.94282053 |
| 67 | MAP3K13 | 0.94223597 |
| 68 | CSNK1G2 | 0.94203785 |
| 69 | CSNK1A1L | 0.93472106 |
| 70 | CSNK1G3 | 0.92962896 |
| 71 | LATS2 | 0.92137046 |
| 72 | MAPKAPK5 | 0.91998535 |
| 73 | NME1 | 0.90474310 |
| 74 | SGK2 | 0.90423555 |
| 75 | MAP3K1 | 0.90363867 |
| 76 | KSR2 | 0.88790722 |
| 77 | TGFBR2 | 0.88119763 |
| 78 | TAOK3 | 0.87287579 |
| 79 | MARK2 | 0.86874175 |
| 80 | SGK3 | 0.86872832 |
| 81 | PHKG1 | 0.86787480 |
| 82 | PHKG2 | 0.86787480 |
| 83 | BTK | 0.85454509 |
| 84 | RIPK1 | 0.85436728 |
| 85 | NTRK1 | 0.84271370 |
| 86 | MAP3K14 | 0.81877459 |
| 87 | PBK | 0.81303036 |
| 88 | ROCK2 | 0.80261836 |
| 89 | IRAK4 | 0.80248946 |
| 90 | TNIK | 0.78833552 |
| 91 | ERN1 | 0.78397969 |
| 92 | IKBKE | 0.77503092 |
| 93 | KIT | 0.77221917 |
| 94 | DDR2 | 0.76814117 |
| 95 | ADRBK2 | 0.76393396 |
| 96 | PAK3 | 0.74865298 |
| 97 | INSRR | 0.74426313 |
| 98 | MAPK4 | 0.74281760 |
| 99 | LATS1 | 0.71901906 |
| 100 | MAP2K6 | 0.71899153 |
| 101 | JAK3 | 0.71724491 |
| 102 | DYRK1A | 0.71684487 |
| 103 | PRKCE | 0.71243429 |
| 104 | KSR1 | 0.70317634 |
| 105 | TYRO3 | 0.69747274 |
| 106 | LCK | 0.69499710 |
| 107 | FYN | 0.68701871 |
| 108 | MAP3K11 | 0.65881149 |
| 109 | CAMK4 | 0.64540466 |
| 110 | STK11 | 0.64486777 |
| 111 | LYN | 0.64287371 |
| 112 | SGK223 | 0.64118339 |
| 113 | SGK494 | 0.64118339 |
| 114 | CAMK1 | 0.63805144 |
| 115 | CAMK2D | 0.63748122 |
| 116 | STK10 | 0.63746038 |
| 117 | CSNK1G1 | 0.61795340 |
| 118 | PDPK1 | 0.61070021 |
| 119 | TAOK2 | 0.61056709 |
| 120 | FGFR3 | 0.59043404 |
| 121 | STK38 | 0.58766796 |
| 122 | CSK | 0.58345635 |
| 123 | PRKD1 | 0.57763721 |
| 124 | MATK | 0.57633205 |
| 125 | CLK1 | 0.57285539 |
| 126 | PRKCZ | 0.57074597 |
| 127 | DMPK | 0.56902054 |
| 128 | AKT3 | 0.55293495 |
| 129 | ICK | 0.55049146 |
| 130 | NEK6 | 0.54501880 |
| 131 | BMPR1B | 0.53628633 |
| 132 | TNK2 | 0.53472977 |
| 133 | MAPK7 | 0.53214778 |
| 134 | CSF1R | 0.52376846 |
| 135 | WNK3 | 0.51952888 |
| 136 | IKBKB | 0.51680440 |
| 137 | ABL2 | 0.51542868 |
| 138 | MAP3K5 | 0.51507030 |
| 139 | EGFR | 0.51423649 |
| 140 | PDK1 | 0.51217678 |
| 141 | PRKCH | 0.50839357 |
| 142 | PRKCG | 0.50761096 |
| 143 | HCK | 0.48554534 |
| 144 | MAP4K1 | 0.47765583 |
| 145 | WNK1 | 0.47417393 |
| 146 | MAP3K6 | 0.46976271 |
| 147 | SIK3 | 0.46710926 |
| 148 | MET | 0.46393776 |
| 149 | TBK1 | 0.45786977 |
| 150 | CAMK2G | 0.45007135 |
| 151 | ADRBK1 | 0.44871844 |
| 152 | GSK3A | 0.43956961 |
| 153 | MST4 | 0.43811522 |
| 154 | FGFR4 | 0.43079440 |
| 155 | RET | 0.42301985 |
| 156 | SGK1 | 0.41803935 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.86788674 |
| 2 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.33282890 |
| 3 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.17750398 |
| 4 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.01535795 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 1.99401048 |
| 6 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.99263473 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 1.70769300 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.68029897 |
| 9 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.67374548 |
| 10 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.65846329 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.61738639 |
| 12 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.57090528 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.54927138 |
| 14 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.54556414 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.54168055 |
| 16 | Alzheimers disease_Homo sapiens_hsa05010 | 1.51002849 |
| 17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.48034324 |
| 18 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.47735240 |
| 19 | GABAergic synapse_Homo sapiens_hsa04727 | 1.45703208 |
| 20 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.43441812 |
| 21 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.42509295 |
| 22 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.42250284 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.41979795 |
| 24 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.40024740 |
| 25 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.39347365 |
| 26 | Axon guidance_Homo sapiens_hsa04360 | 1.35373580 |
| 27 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.32352654 |
| 28 | Circadian entrainment_Homo sapiens_hsa04713 | 1.30237570 |
| 29 | Morphine addiction_Homo sapiens_hsa05032 | 1.27876596 |
| 30 | Long-term potentiation_Homo sapiens_hsa04720 | 1.27739390 |
| 31 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.27667858 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.25262570 |
| 33 | Histidine metabolism_Homo sapiens_hsa00340 | 1.25138045 |
| 34 | Salivary secretion_Homo sapiens_hsa04970 | 1.23555991 |
| 35 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.23029311 |
| 36 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.21703920 |
| 37 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.20867203 |
| 38 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.17618305 |
| 39 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.15413192 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.13726724 |
| 41 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.12702888 |
| 42 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.12304622 |
| 43 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.11768827 |
| 44 | Long-term depression_Homo sapiens_hsa04730 | 1.11736729 |
| 45 | Parkinsons disease_Homo sapiens_hsa05012 | 1.11676671 |
| 46 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.09686889 |
| 47 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.09445902 |
| 48 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.06365539 |
| 49 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.05363737 |
| 50 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.04387965 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.03592945 |
| 52 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.01611675 |
| 53 | Platelet activation_Homo sapiens_hsa04611 | 1.01311374 |
| 54 | Lysosome_Homo sapiens_hsa04142 | 1.00842574 |
| 55 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.99562040 |
| 56 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.98268875 |
| 57 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.95055921 |
| 58 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.94678307 |
| 59 | Influenza A_Homo sapiens_hsa05164 | 0.93853523 |
| 60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.93593754 |
| 61 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.93493538 |
| 62 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.93088995 |
| 63 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.92691060 |
| 64 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.92010736 |
| 65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.90631587 |
| 66 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.90116625 |
| 67 | Taste transduction_Homo sapiens_hsa04742 | 0.88236112 |
| 68 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.88058691 |
| 69 | Asthma_Homo sapiens_hsa05310 | 0.86471864 |
| 70 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.85593788 |
| 71 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.85431118 |
| 72 | Hepatitis B_Homo sapiens_hsa05161 | 0.84991614 |
| 73 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.84677619 |
| 74 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.84626948 |
| 75 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.84102253 |
| 76 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.83242780 |
| 77 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.82517803 |
| 78 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.82475056 |
| 79 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.82151271 |
| 80 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.81652933 |
| 81 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.81582884 |
| 82 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.81461938 |
| 83 | Amoebiasis_Homo sapiens_hsa05146 | 0.80134724 |
| 84 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.79885721 |
| 85 | Measles_Homo sapiens_hsa05162 | 0.79368541 |
| 86 | Endometrial cancer_Homo sapiens_hsa05213 | 0.79354666 |
| 87 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.79012845 |
| 88 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.78147794 |
| 89 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.77888522 |
| 90 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.77123830 |
| 91 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.76676718 |
| 92 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.76460708 |
| 93 | Cocaine addiction_Homo sapiens_hsa05030 | 0.76421425 |
| 94 | Viral myocarditis_Homo sapiens_hsa05416 | 0.75849694 |
| 95 | Apoptosis_Homo sapiens_hsa04210 | 0.74204734 |
| 96 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.74036906 |
| 97 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.74024131 |
| 98 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.73572712 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.73069139 |
| 100 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.72572172 |
| 101 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.72153800 |
| 102 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69591820 |
| 103 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.69052675 |
| 104 | Other glycan degradation_Homo sapiens_hsa00511 | 0.68284973 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68262535 |
| 106 | Hepatitis C_Homo sapiens_hsa05160 | 0.68180907 |
| 107 | Bile secretion_Homo sapiens_hsa04976 | 0.67849275 |
| 108 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.67725693 |
| 109 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.66505604 |
| 110 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.66302243 |
| 111 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.65330419 |
| 112 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64519031 |
| 113 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.63531583 |
| 114 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.63433566 |
| 115 | Legionellosis_Homo sapiens_hsa05134 | 0.63007583 |
| 116 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.63005183 |
| 117 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.62821849 |
| 118 | Phagosome_Homo sapiens_hsa04145 | 0.62733876 |
| 119 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.62197482 |
| 120 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.62046447 |
| 121 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.61964836 |
| 122 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.61863057 |
| 123 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.61798194 |
| 124 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.61731457 |
| 125 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.61210498 |
| 126 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.60284607 |
| 127 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.59646068 |
| 128 | Peroxisome_Homo sapiens_hsa04146 | 0.59036844 |
| 129 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.58774609 |
| 130 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.58276276 |
| 131 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.58060139 |
| 132 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.57662834 |
| 133 | Gap junction_Homo sapiens_hsa04540 | 0.57065290 |
| 134 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56459957 |
| 135 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.55332923 |
| 136 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.54488945 |
| 137 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53111152 |
| 138 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.52685296 |
| 139 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.51848961 |
| 140 | Malaria_Homo sapiens_hsa05144 | 0.51256980 |
| 141 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.51093718 |
| 142 | Pertussis_Homo sapiens_hsa05133 | 0.49828021 |
| 143 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.48911491 |
| 144 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.48697241 |
| 145 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48385970 |
| 146 | Salmonella infection_Homo sapiens_hsa05132 | 0.48108339 |
| 147 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.46625775 |
| 148 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44102685 |
| 149 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.43457590 |
| 150 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.43260059 |
| 151 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.42553755 |
| 152 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.41987036 |
| 153 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.40445519 |
| 154 | Tuberculosis_Homo sapiens_hsa05152 | 0.40076044 |
| 155 | Huntingtons disease_Homo sapiens_hsa05016 | 0.39911474 |

